2025 PNS Annual Meeting, 17-20 May

We are delighted to announce that CSL Behring will organise and support a symposium for healthcare professionals only at the 2025 PNS Annual Meeting:

“Optimising Patient Outcomes in CIDP: A Comprehensive Approach”
Monday 19 May, 13:10–14:10 CET

Luis Querol, Spain, and Michael Lunn, UK, will co-chair the symposium and lead the thought-provoking discussion around the mechanisms of action of key CIDP therapies, and strategies to optimise these therapies to improve patient outcomes.

Luis Querol’s presentation will focus on the mechanisms of action of key therapies for CIDP, including steroids, immunoglobulins and FcRn blockers.

Michael Lunn’s presentation will focus on the optimisation of CIDP therapies to improve patient outcomes, including the best therapy approaches for individual patients and the impact of patient education on treatment adherence and outcomes.

Prescribing Information for CSL Behring products discussed will be available at the meeting. Licence conditions may vary between countries - please refer to your national Prescribing Information.

Register for the 2025 PNS Annual Meeting here:
Register here | 2025 PNS

We look forward to seeing you in Edinburgh this May, and please keep an eye out for on-demand content after the event.